CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 47 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-01 | LOBELL J JAY Director | Grant or award | +100,000 | 786,000 | ||
| 2018-01-01 | Rowinsky Eric K Director | Grant or award | +100,000 | 450,000 | ||
| 2017-12-14 | Avgerinos George SVP, BIOLOGICS OPERATIONS | Sale | −12,000 | $3.55 | $43K | 352,495 |
| 2017-12-13 | Avgerinos George SVP, BIOLOGICS OPERATIONS | Sale | −19,000 | $3.57 | $68K | 364,495 |
| 2017-12-12 | Avgerinos George SVP, BIOLOGICS OPERATIONS | Sale | −25,593 | $3.59 | $92K | 383,495 |
| 2017-11-29 | Avgerinos George SVP, BIOLOGICS OPERATIONS | Grant or award | +150,000 | 409,088 | ||
| 2017-11-06 | ROSENWALD LINDSAY A MD PRESIDENT, CEO | Purchase | +40,000 | $25.00 | $1.0M | 40,000 |
| 2017-07-14 | Klein Dov Director | Returned to the company | −13,333 | 201,668 | ||
| 2017-07-14 | Klein Dov Director | Grant or award · Deferred Restricted Stock Units | +13,333 | 53,332 | ||
| 2017-03-10 | Hoenlein Malcolm Director | Grant or award · Deferred Restricted Stock Units | +16,666 | 49,998 | ||
| 2017-03-10 | Harvey Jimmie Director | Grant or award · Deferred Restricted Stock Units | +16,666 | 49,998 | ||
| 2017-03-10 | Harvey Jimmie Director | Grant or award · Deferred Restricted Stock Units | +16,666 | 49,998 | ||
| 2017-01-01 | WEISS MICHAEL S Exec. VC - Strategic Dev. | Grant or award | +552,698 | 8,001,170 | ||
| 2017-01-01 | ROSENWALD LINDSAY A MD President and CEO | Grant or award | +552,698 | 5,857,168 | ||
| 2017-01-01 | Rowinsky Eric K Director | Grant or award | +100,000 | 350,000 | ||
| 2017-01-01 | LOBELL J JAY Director | Grant or award | +100,000 | 686,000 | ||
| 2017-01-01 | Klein Dov Director | Grant or award | +100,000 | 241,667 | ||
| 2017-01-01 | Klein Dov Director | Returned to the company | −26,666 | 215,001 | ||
| 2017-01-01 | Klein Dov Director | Grant or award · Deferred Restricted Stock Units | +26,666 | 39,999 | ||
| 2017-01-01 | Hoenlein Malcolm Director | Grant or award · Deferred Restricted Stock Units | +16,666 | 33,332 |
Page 8 of 12 · 231 trades